Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Attention Disorders"
DOI: 10.1177/1087054719896853
Abstract: Objective: To evaluate the efficacy and safety of a 16-hr multilayer-release methylphenidate (PRC-063) in a community-based adult ADHD population. Method: In a double-blind study, 375 participants were randomized to one of four fixed doses of… read more here.
Keywords: open label; prc 063; safety; study ... See more keywords
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of attention disorders"
DOI: 10.1177/10870547211025610
Abstract: OBJECTIVE To evaluate the efficacy, safety, and duration of action of the once-daily extended-release methylphenidate formulation PRC-063 for the treatment of ADHD in an adult laboratory classroom (ALC). METHOD After dose optimization with PRC-063 over… read more here.
Keywords: extended release; efficacy safety; treatment; placebo ... See more keywords
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Attention Disorders"
DOI: 10.1177/10870547241226634
Abstract: Objective: To compare PRC-063 (multilayer-release methylphenidate) and lisdexamfetamine dimesylate (LDX) on the driving performance of young adults with attention deficit hyperactivity disorder (ADHD) in a randomized, double-blind, crossover study. Method: Following up to 21 days of… read more here.
Keywords: performance young; prc 063; release methylphenidate; driving performance ... See more keywords